This week we were happy to see plenty of activity in European companies, which are aiming to grow their market presence in the US. There was also massive variety in the types of technology funded – from exoskeletons to sleep headbands.
Wandercraft raises $75m to support AI-powered robotic exoskeleton
Renault Group, PSIM fund (managed on behalf of the French State by Bpifrance), Teampact Ventures and Quadrant Management contributed to the $75 million Series D funding round, which will support the company’s robotic exoskeleton.
Renault Group owns a minority stake and has a strategic partnership with the company, looking to bring industrial expertise to help scale up Wandercraft’s offerings.
CEO and co-founder Matthieu Masselin
Atraverse raises $29.4m for left-heart access device
Atraverse secured an oversubscribed $12.5m seed funding round last year. This follow-on funding builds on that round, bringing the company’s total funding to more than $40 million in investment capital.
The early rollout of the Hotwire radiofrequency guidewire left-heart access device has begun, and the new funding will support manufacturing and product development.
CEO, president, and co-founder John Slump
Aortyx raises $16m for bioresorbable aortic patch technology
The funding will support the company’s bioresorbable aortic patch technology and bring it to first-in-human tests within two years.
Funding came from Ship2B Ventures, through its BSocial Impact Fund (supported by Banco Sabadell, the EIF, and AXIS), and Clave Capital, through Clave Innohealth (supported by CDTI-Innvierte). Nara Capital, the EIC fund, CDTI Innvierte, angel investors and an unnamed top aortic device manufacturer also joined.
CEO and co-founder Jordi Martorel
Somnee raises $10m for AI neurotech sleep wearables
The seed extension round will aid the launch of the company’s second-generation smart sleep headband, which can provide personalised stimulation to improve sleep.
Khosla Ventures led the round with contributions from Marc Benioff’s TIME Ventures, the DeVos family of the NBA’s Orlando Magic, LEAD VC, Seaside Ventures, Metalab, and Nelstone Ventures.
CEO Tim Rosa
Dilon Technologies closes $9m in Growth Capital Financing
The growth capital investment comes from JGB Management. It will support Dilon’s continued double-digit revenue growth and operational scaling, as they continue their mission to deliver evidence-based surgical solutions worldwide.
Key products include HEMOBLAST Bellows, MarginProbe, Navigator Gamma Probe, and more.
CEO George Makhoul
Flux Robotics secures pre-seed funding to accelerate safer magnetic surgeries
The round was supported by Future Tech Ventures and NextGen Ventures and further complemented by public support through a Health~Holland PPP subsidy, facilitated via a collaboration with the University Medical Center Groningen.
The company will use the proceeds to complete pre-clinical trials, refine the Flux 2 navigational system, and grow engineering and clinical teams.
CEO Christoff Heunis
Positrigo closes $8.5m funding round
The Swiss-based company closed a financing round valued at 7 million Swiss francs to accelerate production of its NeuroLF system for functional brain imaging using PET and focus on commercial rollout in the U.S.
HealthCap and Navivo Capital were the lead investors in the round. Positrigo also welcomed new members to its board.
Founder and CEO Dr. Jannis Fischer
